Kestra Medical Technologies Ltd. (KMTS)
26.17
+1.26
(+5.06%)
USD |
NASDAQ |
Dec 12, 16:00
26.20
+0.02
(+0.10%)
After-Hours: 20:00
Kestra Medical Technologies Research and Development Expense (Quarterly): 4.878M for Oct. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Bruker Corp. | 98.30M |
| Azenta, Inc. | 8.258M |
| Harvard Bioscience, Inc. | 2.132M |
| Phibro Animal Health Corp. | -- |
| Bionano Genomics, Inc. | 2.844M |